Zymergen

Joshua Hoffman, CEO
Joshua Hoffman, CEO
Country: USA | Funding: $974.1M (+)

Zymergen engineers better microbes that make useful molecules, which are part of all the materials in our daily lives. We are engineering biology predictably, reliably and to levels of performance unattainable through traditional R&D methods. Our comprehensive approach brings together technology, automation, and biology with the most sophisticated capabilities in each. Acquired by Ginkgo Bioworks